Unknown

Dataset Information

0

STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.


ABSTRACT: Although type I IFNs play critical roles in antiviral and antitumor activity, it remains to be elucidated how type I IFNs are produced in sterile conditions of the tumor microenvironment and directly affect tumor-infiltrating immune cells. Mouse de novo gliomas show increased expression of type I IFN messages, and in mice, CD11b(+) brain-infiltrating leukocytes (BIL) are the main source of type I IFNs that are induced partially in a STING (stimulator of IFN genes)-dependent manner. Consequently, glioma-bearing Sting(Gt) (/Gt) mice showed shorter survival and lower expression levels of Ifns compared with wild-type mice. Furthermore, BILs of Sting(Gt) (/Gt) mice showed increased CD11b(+) Gr-1(+) immature myeloid suppressor and CD25(+) Foxp3(+) regulatory T cells (Treg) and decreased IFN?-producing CD8(+) T cells. CD4(+) and CD8(+) T cells that received direct type I IFN signals showed lesser degrees of regulatory activity and increased levels of antitumor activity, respectively. Finally, intratumoral administration of a STING agonist (cyclic diguanylate monophosphate; c-di-GMP) improved the survival of glioma-bearing mice associated with enhanced type I IFN signaling, Cxcl10 and Ccl5, and T-cell migration into the brain. In combination with subcutaneous OVA peptide vaccination, c-di-GMP increased OVA-specific cytotoxicity of BILs and prolonged their survival. These data demonstrate significant contributions of STING to antitumor immunity via enhancement of type I IFN signaling in the tumor microenvironment and suggest a potential use of STING agonists for the development of effective immunotherapy, such as the combination with antigen-specific vaccinations.

SUBMITTER: Ohkuri T 

PROVIDER: S-EPMC4258479 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.

Ohkuri Takayuki T   Ghosh Arundhati A   Kosaka Akemi A   Zhu Jianzhong J   Ikeura Maki M   David Michael M   Watkins Simon C SC   Sarkar Saumendra N SN   Okada Hideho H  

Cancer immunology research 20141009 12


Although type I IFNs play critical roles in antiviral and antitumor activity, it remains to be elucidated how type I IFNs are produced in sterile conditions of the tumor microenvironment and directly affect tumor-infiltrating immune cells. Mouse de novo gliomas show increased expression of type I IFN messages, and in mice, CD11b(+) brain-infiltrating leukocytes (BIL) are the main source of type I IFNs that are induced partially in a STING (stimulator of IFN genes)-dependent manner. Consequently,  ...[more]

Similar Datasets

2021-10-09 | GSE181745 | GEO
| S-EPMC8300883 | biostudies-literature
| S-EPMC7323848 | biostudies-literature
| S-EPMC4440852 | biostudies-literature
| S-EPMC5969905 | biostudies-literature
| S-EPMC7460725 | biostudies-literature
| S-EPMC5826801 | biostudies-literature
| S-EPMC7494563 | biostudies-literature
| S-EPMC6599017 | biostudies-literature
| S-EPMC3879373 | biostudies-literature